Friday, March 19, 2021 10:01:31 AM
Regardless how you read and analyze the data available to day about DCVax-L trial, the SOC, and the commercially available Optune device, and the conclusion you may draw from;
Regardless how you rate LP, and the management team, their strategy and what they have done today;
As least we all agree GMB is a deadest kind of cancer with unmet need in real life.
And the market agrees DCVax-L will get approved by four RAs by assigning a market cap of about $1.3 billion before TLD.
First step, confirm the market is right with positive tld of which it's almost certain the primary endpoint will be readily met with some unheard data showing long term survivals of three, four, five years.
Then, ten fold MC increase will be in the card (around $13 billion)for job well done and speculation of hefty revenue
Then, reasonable multiple will be given (up to $20 billion MC) considering other indications with now approved MOA.
In sequel or parallel, money will fly wilder and higher as DCVax-D comes to mind....
Not many retail investors will have the gut, wit and experience to hold for the big prize. They are born for pennies. I have seen this happening no end, and that's the nature of it.
When we see that accelerate we are real close regardless the term of in coming month or days or years. when it comes it arrives! Ladies and gentlemen, market is forward looking, it acts most times out of expectation!
Have I mentioned now I have been also adding shares to my wife accounts, about 100,000 now.
End of my rambling.
[Just realize this post is not intended in reply to RobotDroid. Sorry for that]
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM